Evidence map›Paper›PMID 28699034›Full record

ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2017

[Definition of R1 resection in thyroid carcinoma].

S Synoracki, Ch Wittekind, H Dralle, K W Schmid

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Malignant teratoma of the thyroid.BMJ case reports · 2021
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S SynorackiInstitut für Pathologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Deutschland.
Ch WittekindInstitut für Pathologie, Universitätsklinikum Leipzig, Leipzig, Deutschland.
H DralleKlinik für Allgemeinchirurgie, Viszeral- und Transplantationschirurgie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Deutschland.
K W SchmidInstitut für Pathologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstraße 55, 45147, Essen, Deutschland. kw.schmid@uk-essen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe residual tumor (R) classification describes the tumor status after therapy, which in patients with thyroid carcinomas is predominantly after surgical treatment. The aim of the R classification is to indicate the success of (surgical) therapy, which can influence further therapeutic procedures and allow relevant prognostic statements.

objectiveDefinition of R1 resection as well as minimally invasive extrathyroidal growth of thyroid carcinomas as the latter is a common prerequisite for R1 resected thyroid carcinoma.

resultsPresentation of the pathological work-up and histopathological assessment. Proposal to supplement and extend the recently introduced 8th edition of the TNM classification in order to systematically classify minimally invasive extrathyroidal carcinomas.

conclusionThe presented definitions (e.g. R1, minimally invasive extrathyroidal invasion) in combination with the proposed extension of the TNM classification permit the prospective scientific assessment of the biological relevance of these two parameters.

Indexed as

HumansNeoplasm InvasivenessNeoplasm, ResidualNeoplasm StagingPrognosisThyroidectomyThyroid GlandThyroid NeoplasmsHistologyMinimally invasive extrathyroidal growthPrognostic relevanceResidual tumorTNM classification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.